Convey Health Solutions Holdings, Inc. Increase (Decrease) in Accounts Payable and Accrued Liabilities
Convey Health Solutions Holdings, Inc. reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of -$21.01 million for the 6-month period ending 2022-06-30, per its 10-Q filed 2022-08-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2022-08-12
- Convey Health Solutions Holdings, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2022-06-30 was $5.22M, a 21.53% increase year-over-year.
- Convey Health Solutions Holdings, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2022-03-31 was -$26.22M.
- Convey Health Solutions Holdings, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2021-12-31 was $5.46M, a 68.22% decline year-over-year.
- Convey Health Solutions Holdings, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2021-09-30 was $4.66M, a 48.62% decline year-over-year.
- Convey Health Solutions Holdings, Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2021 was -$7.69M, a 125.91% decline from fiscal 2020.
- Convey Health Solutions Holdings, Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2020 was $29.66M.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 7 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 8 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month |
|---|---|---|---|---|---|---|
| 2022-06-30 | $5.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | -$21.01M 10-Q · filed 2022-08-12 | -$15.55M derived: sum of 3 quarters · filed 2022-08-12 | -$10.88M derived: sum of 4 quarters · filed 2022-08-12 | ||
| 2022-03-31 | -$26.22M 10-Q · filed 2022-05-10 | -$20.76M derived: sum of 2 quarters · filed 2022-05-10 | -$16.10M derived: sum of 3 quarters · filed 2022-05-10 | -$11.81M derived: sum of 4 quarters · filed 2022-08-12 | ||
| 2021-12-31 | $5.46M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | $10.12M derived: sum of 2 quarters · filed 2022-03-23 | $14.41M derived: sum of 3 quarters · filed 2022-08-12 | -$7.69M 10-K · filed 2022-03-23 | ||
| 2021-09-30 | $4.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $8.96M derived: sum of 2 quarters · filed 2022-08-12 | -$13.14M 10-Q · filed 2021-11-10 | $4.03M derived: sum of 4 quarters · filed 2022-08-12 | ||
| 2021-06-30 | $4.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | -$17.81M 10-Q · filed 2022-08-12 | -$632.00K derived: sum of 3 quarters · filed 2022-08-12 | $8.44M derived: sum of 4 quarters · filed 2022-08-12 | ||
| 2021-03-31 | -$22.10M 10-Q · filed 2022-05-10 | -$4.92M derived: sum of 2 quarters · filed 2022-05-10 | $4.15M derived: sum of 3 quarters · filed 2022-05-10 | |||
| 2020-12-31 | $17.18M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | $26.25M derived: sum of 2 quarters · filed 2022-03-23 | $29.66M 10-K · filed 2022-03-23 | |||
| 2020-09-30 | $9.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $12.48M 10-Q · filed 2021-11-10 | ||||
| 2020-06-30 | $3.41M 10-Q · filed 2021-08-12 | |||||
| 2019-12-31 | $6.02M 10-K · filed 2022-03-23 | |||||
| 2019-09-03 | $12.57M 10-K · filed 2022-03-23 |